174 related articles for article (PubMed ID: 26575329)
1. KIAA0101 is associated with human renal cell carcinoma proliferation and migration induced by erythropoietin.
Fan S; Li X; Tie L; Pan Y; Li X
Oncotarget; 2016 Mar; 7(12):13520-37. PubMed ID: 26575329
[TBL] [Abstract][Full Text] [Related]
2. Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.
Stoyanoff TR; Rodríguez JP; Todaro JS; Espada JD; Colavita JP; Brandan NC; Torres AM; Aguirre MV
Tumour Biol; 2016 Oct; 37(10):13581-13593. PubMed ID: 27468719
[TBL] [Abstract][Full Text] [Related]
3. The erythropoietin/erythropoietin receptor signaling pathway promotes growth and invasion abilities in human renal carcinoma cells.
Wu P; Zhang N; Wang X; Zhang C; Li T; Ning X; Gong K
PLoS One; 2012; 7(9):e45122. PubMed ID: 23028796
[TBL] [Abstract][Full Text] [Related]
4. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
[TBL] [Abstract][Full Text] [Related]
5. Integrative bioinformatics analysis reveals new prognostic biomarkers of clear cell renal cell carcinoma.
Butz H; Szabó PM; Nofech-Mozes R; Rotondo F; Kovacs K; Mirham L; Girgis H; Boles D; Patocs A; Yousef GM
Clin Chem; 2014 Oct; 60(10):1314-26. PubMed ID: 25139457
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions.
Miyake M; Goodison S; Lawton A; Zhang G; Gomes-Giacoia E; Rosser CJ
J Hematol Oncol; 2013 Sep; 6():65. PubMed ID: 24004818
[TBL] [Abstract][Full Text] [Related]
7. MUC13 overexpression in renal cell carcinoma plays a central role in tumor progression and drug resistance.
Sheng Y; Ng CP; Lourie R; Shah ET; He Y; Wong KY; Seim I; Oancea I; Morais C; Jeffery PL; Hooper J; Gobe GC; McGuckin MA
Int J Cancer; 2017 May; 140(10):2351-2363. PubMed ID: 28205224
[TBL] [Abstract][Full Text] [Related]
8. Decitabine induces G2/M cell cycle arrest by suppressing p38/NF-κB signaling in human renal clear cell carcinoma.
Shang D; Han T; Xu X; Liu Y
Int J Clin Exp Pathol; 2015; 8(9):11140-8. PubMed ID: 26617834
[TBL] [Abstract][Full Text] [Related]
9. High TXNDC5 expression predicts poor prognosis in renal cell carcinoma.
Mo R; Peng J; Xiao J; Ma J; Li W; Wang J; Ruan Y; Ma S; Hong Y; Wang C; Gao K; Fan J
Tumour Biol; 2016 Jul; 37(7):9797-806. PubMed ID: 26810069
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin stimulates proliferation of human renal carcinoma cells.
Westenfelder C; Baranowski RL
Kidney Int; 2000 Aug; 58(2):647-57. PubMed ID: 10916088
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin gene expression in renal carcinoma is considerably more frequent than paraneoplastic polycythemia.
Wiesener MS; Münchenhagen P; Gläser M; Sobottka BA; Knaup KX; Jozefowski K; Jürgensen JS; Roigas J; Warnecke C; Gröne HJ; Maxwell PH; Willam C; Eckardt KU
Int J Cancer; 2007 Dec; 121(11):2434-42. PubMed ID: 17640059
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma.
Sato A; Nagase H; Obinata D; Fujiwara K; Fukuda N; Soma M; Yamaguchi K; Kawata N; Takahashi S
Int J Oncol; 2013 Nov; 43(5):1441-6. PubMed ID: 23969530
[TBL] [Abstract][Full Text] [Related]
14. Triiodothyronine regulates cell growth and survival in renal cell cancer.
Czarnecka AM; Matak D; Szymanski L; Czarnecka KH; Lewicki S; Zdanowski R; Brzezianska-Lasota E; Szczylik C
Int J Oncol; 2016 Oct; 49(4):1666-78. PubMed ID: 27632932
[TBL] [Abstract][Full Text] [Related]
15. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q
Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566
[TBL] [Abstract][Full Text] [Related]
16. Expression of erythropoietin and its receptor in human renal cell carcinoma.
Papworth K; Bergh A; Grankvist K; Ljungberg B; Rasmuson T
Tumour Biol; 2009; 30(2):86-92. PubMed ID: 19407488
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression.
Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
J Cancer Res Clin Oncol; 2018 Jan; 144(1):39-52. PubMed ID: 28993942
[TBL] [Abstract][Full Text] [Related]
18. MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma.
Tong S; Si Y; Yu H; Zhang L; Xie P; Jiang W
Sci Rep; 2017 Jul; 7(1):5599. PubMed ID: 28717191
[TBL] [Abstract][Full Text] [Related]
19. SUSD2 is frequently downregulated and functions as a tumor suppressor in RCC and lung cancer.
Cheng Y; Wang X; Wang P; Li T; Hu F; Liu Q; Yang F; Wang J; Xu T; Han W
Tumour Biol; 2016 Jul; 37(7):9919-30. PubMed ID: 26815503
[TBL] [Abstract][Full Text] [Related]
20. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN.
Deng W; Han W; Fan T; Wang X; Cheng Z; Wan B; Chen J
Biomed Pharmacother; 2018 Nov; 107():1505-1513. PubMed ID: 30257368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
